Develops biologic therapeutics targeting key immune regulators, aiming to restore balance in autoimmune and inflammatory diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Q32 Bio is a clinical-stage biotechnology company developing biologic therapeutics that target key regulators of the immune system to restore balance in autoimmune and inflammatory diseases. Their lead programs include bempikibart (ADX-914), an anti-IL-7Rα antibody aimed at re-regulating adaptive immune function, and ADX-097, a tissue-targeted complement inhibitor designed to address innate immune dysregulation.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Q32 Bio Management Team
Q32 Bio Valuations & Financials
View real-time NPM data on Q32 Bio stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Q32 Bio
Lyra
Health Care
Digital health startup using technology to connect companies and employees to mental health providers.
Eikon Therapeutics
Health Care
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Tonal
Health Care
Delivers AI-powered strength training with digital weights and personalized coaching.
Curology
Health Care
Offers personalized prescription skin care medications delivered directly to you.
Devoted
Health Care
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Cerebral
Health Care
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Somatus
Health Care
Integrated care for patients with or at risk of developing kidney disease.
FAQ
We have answers
Q32 Bio stock does not trade on public stock exchanges. Q32 Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Q32 Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Q32 Bio Stock does not trade on public stock exchanges. In order to sell Q32 Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Q32 Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Q32 Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Q32 Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Q32 Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Q32 Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Q32 Bio is a private company and has not had an IPO. There is currently no Q32 Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Q32 Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
